Detection of carbonic anhydrase IX protein in the diagnosis of malignant pleural effusion by enzyme-linked immunosorbent assay and immunocytochemistry

Cancer Cytopathology

Volumn 120, Issue 4, 2012, Pages 269-275

  Liao, Nai Ding ^a   Lee, Wen Ying ^a,b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Carbonic anhydrase IX; Cell block; Enzyme linked immunosorbent assay; Immunocytochemistry; Pleural effusion

Indexed keywords

CARBONATE DEHYDRATASE IX; CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ENZYME IMMUNOASSAY; ENZYMOLOGY; FOLLOW UP; METABOLISM; NEOPLASM; PATHOLOGY; PROGNOSIS;

AGED; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASMS; PLEURAL EFFUSION, MALIGNANT; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84868220610     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21191     Document Type: Article

References (28)

1. Marel M, Stastny B, Melinova L, et al. Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990. Chest. 1995; 107:1598-1603.
2. Heffner JE. Discriminating between transudates and exudates. Clin Chest Med. 2006;27:241-252.
3. Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Primary Study Investigators. Chest. 1997;111:970-980.
4. Motherby H, Nadjari B, Friegel P, et al. Diagnostic accuracy of effusion cytology. Diagn Cytopathol. 1999;20:350-357.
5. Prakash UB, Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc. 1985;60:158-164.
6. Tassi GF, Cardillo G, Marchetti GP, et al. Diagnostic and therapeutical management of malignant pleural effusion. Ann Oncol. 2006;17(suppl 2):ii11-ii12.
7. Shitrit D, Zingerman B, Shitrit AB, et al. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. Oncologist. 2005;10:501-507.
8. Huang WW, Tsao SM, Lai CL, et al. Diagnostic value of Her-2/ neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma. Pathology. 2010;42:224-228.
9. Porcel JM, Vives M, Esquerda A, et al. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest. 2004;126:1757-1763.
10. Light RW. Tumor markers in undiagnosed pleural effusions. Chest. 2004;126:1721-1722.
11. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev. 2004;4:891-899.
12. Fang JS, Gillies RD, Gatenby RA. Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin Cancer Biol. 2008;18:330-337.
13. Griffiths JR, McIntyre DJ, Howe FA, et al. Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid. Novartis Found Symp. 2001;240:46-62.
14. Robertson N, Potter C, Harris AL. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Res. 2004;64:6160-6165.
15. Lee WY, Huang SC, Hsu KF, et al. Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis- acidosis sequence. Gynecol Oncol. 2008;108:377-384.
16. Chen CL, Chu JS, Su WC, et al. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX. Virchows Arch. 2010;457:53-61.
17. Swinson DE, Jones JL, Richardson D, et al. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol. 2003;21:473-482.
18. Chen J, Rocken C, Hoffmann J, et al. Expression of carbonic anhydrase 9 at the invasion front of gastric cancers. Gut. 2005;54:920-927.
19. Li G, Passebosc-Faure K, Feng G, et al. MN/CA9: a potential gene marker for detection of malignant cells in effusions. Biomarkers. 2007;12:214-220.
20. Zhou GX, Ireland J, Rayman P, et al. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials. Urology. 2010;75:257-261.
21. Shi HZ, Liang QL, Jiang J, et al. Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis. Respirology. 2008;13:518-527.
22. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
23. Yang CT, Lee MH, Lan RS, et al. Telomerase activity in pleural effusions: diagnostic significance. J Clin Oncol. 1998;16:567-573.
24. Lee WY. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination. Cytopathology. 2005;16:227-232.
25. Garcia-Pachon E, Padilla-Navas I, Dosda MD, et al. Elevated level of carcinoembryonic antigen in nonmalignant pleural effusions. Chest. 1997;111:643-647.
26. Lee LJ, Chang YY, Wang JD. Impact of malignant mesothelioma in Taiwan: a 27-year review of population-based cancer registry data. Lung Cancer. 2010;68:16-19.
27. Ramsey ML, Yuh BJ, Johnson MT, et al. Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung. Virchows Arch. 2012;460:89-93.
28. Ivanov S, Liao SY, Ivanova A, et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol. 2001:158:905-919.